Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387473126> ?p ?o ?g. }
- W4387473126 abstract "The antibacterial activity of 22 thiolato-bridged dinuclear ruthenium(II)-arene compounds was assessed in vitro against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. None of the compounds efficiently inhibited the growth of the three E. coli strains tested, and only compound 5 exhibited a medium activity against this bacterium [MIC (minimum inhibitory concentration) of 25 µM]. However, a significant antibacterial activity was observed against S. pneumoniae, with MIC values ranging from 1.3 to 2.6 µM for compounds 1-3, 5, and 6. Similarly, compounds 2, 5-7, and 20-22 had MIC values ranging from 2.5 to 5 µM against S. aureus. The tested diruthenium compounds have a bactericidal effect significantly faster than that of penicillin. Fluorescence microscopy assays performed on S. aureus using the BODIPY-tagged diruthenium complex 15 showed that this type of metal compound enters the bacteria and does not accumulate in the cell wall of gram-positive bacteria. Cellular internalization was further confirmed by inductively coupled plasma mass spectrometry experiments. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appears to significantly influence the antibacterial activity. Thus, if overall a decrease of the bactericidal effect with the increase of compounds' molecular weight is observed, however, the complexes bearing larger benzo-fused lactam substituents had low MIC values. This first antibacterial activity screening demonstrated that the thiolato-diruthenium compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies. IMPORTANCE The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents." @default.
- W4387473126 created "2023-10-11" @default.
- W4387473126 creator A5005783291 @default.
- W4387473126 creator A5028016444 @default.
- W4387473126 creator A5039630514 @default.
- W4387473126 creator A5064779045 @default.
- W4387473126 creator A5076539876 @default.
- W4387473126 creator A5080007157 @default.
- W4387473126 creator A5083931705 @default.
- W4387473126 creator A5093032305 @default.
- W4387473126 date "2023-10-10" @default.
- W4387473126 modified "2023-10-16" @default.
- W4387473126 title "<i>In vitro</i> antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds" @default.
- W4387473126 cites W1700354016 @default.
- W4387473126 cites W1940167135 @default.
- W4387473126 cites W1969044576 @default.
- W4387473126 cites W1994381510 @default.
- W4387473126 cites W2003802915 @default.
- W4387473126 cites W2004332141 @default.
- W4387473126 cites W2007754517 @default.
- W4387473126 cites W2039285794 @default.
- W4387473126 cites W2040215907 @default.
- W4387473126 cites W2050472541 @default.
- W4387473126 cites W2061738878 @default.
- W4387473126 cites W2062780978 @default.
- W4387473126 cites W2092090200 @default.
- W4387473126 cites W2108638835 @default.
- W4387473126 cites W2117606701 @default.
- W4387473126 cites W2130651650 @default.
- W4387473126 cites W2159735109 @default.
- W4387473126 cites W2187465023 @default.
- W4387473126 cites W2294526456 @default.
- W4387473126 cites W2318411069 @default.
- W4387473126 cites W2340371173 @default.
- W4387473126 cites W2414827533 @default.
- W4387473126 cites W2415767932 @default.
- W4387473126 cites W2522223005 @default.
- W4387473126 cites W2636217593 @default.
- W4387473126 cites W2777258817 @default.
- W4387473126 cites W2779019546 @default.
- W4387473126 cites W2910905405 @default.
- W4387473126 cites W2913879165 @default.
- W4387473126 cites W2936122769 @default.
- W4387473126 cites W2951131486 @default.
- W4387473126 cites W2970134449 @default.
- W4387473126 cites W2974012116 @default.
- W4387473126 cites W2982477142 @default.
- W4387473126 cites W3011252523 @default.
- W4387473126 cites W3011719258 @default.
- W4387473126 cites W3013036959 @default.
- W4387473126 cites W3016283926 @default.
- W4387473126 cites W3020256910 @default.
- W4387473126 cites W3027946670 @default.
- W4387473126 cites W3035996599 @default.
- W4387473126 cites W3046808790 @default.
- W4387473126 cites W3097272639 @default.
- W4387473126 cites W3139411888 @default.
- W4387473126 cites W3159592417 @default.
- W4387473126 cites W3170036770 @default.
- W4387473126 cites W3172893495 @default.
- W4387473126 cites W3177125105 @default.
- W4387473126 cites W3183554650 @default.
- W4387473126 cites W3204676410 @default.
- W4387473126 cites W3208116526 @default.
- W4387473126 cites W3209822665 @default.
- W4387473126 cites W4200155515 @default.
- W4387473126 cites W4206677002 @default.
- W4387473126 cites W4224236834 @default.
- W4387473126 cites W4241111610 @default.
- W4387473126 cites W4304203430 @default.
- W4387473126 cites W4316673264 @default.
- W4387473126 cites W4317702614 @default.
- W4387473126 doi "https://doi.org/10.1128/spectrum.00954-23" @default.
- W4387473126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37815336" @default.
- W4387473126 hasPublicationYear "2023" @default.
- W4387473126 type Work @default.
- W4387473126 citedByCount "0" @default.
- W4387473126 crossrefType "journal-article" @default.
- W4387473126 hasAuthorship W4387473126A5005783291 @default.
- W4387473126 hasAuthorship W4387473126A5028016444 @default.
- W4387473126 hasAuthorship W4387473126A5039630514 @default.
- W4387473126 hasAuthorship W4387473126A5064779045 @default.
- W4387473126 hasAuthorship W4387473126A5076539876 @default.
- W4387473126 hasAuthorship W4387473126A5080007157 @default.
- W4387473126 hasAuthorship W4387473126A5083931705 @default.
- W4387473126 hasAuthorship W4387473126A5093032305 @default.
- W4387473126 hasBestOaLocation W43874731261 @default.
- W4387473126 hasConcept C104317684 @default.
- W4387473126 hasConcept C161790260 @default.
- W4387473126 hasConcept C176947019 @default.
- W4387473126 hasConcept C185592680 @default.
- W4387473126 hasConcept C202751555 @default.
- W4387473126 hasConcept C2779489039 @default.
- W4387473126 hasConcept C2780104969 @default.
- W4387473126 hasConcept C2781253189 @default.
- W4387473126 hasConcept C501593827 @default.
- W4387473126 hasConcept C523546767 @default.
- W4387473126 hasConcept C54355233 @default.
- W4387473126 hasConcept C547475151 @default.
- W4387473126 hasConcept C55493867 @default.